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Abstract
Background: Isovolumetric acceleration (IVA) is a novel tissue Doppler parameter for the assessment of systolic
function. The aim of this study was to evaluate IVA as an early parameter for the detection of right ventricular (RV)
systolic dysfunction in patients with systemic sclerosis (SSc) without pulmonary hypertension.
Methods: 22 patients and 22 gender- and age-matched healthy subjects underwent standard echocardiography
with tissue Doppler imaging (TDI) and speckle tracking strain to assess RV function.
Results: Tricuspid annular plane systolic excursion (TAPSE) (23.2 ± 4.1 mm vs. 26.5 ± 2.9 mm, p < 0.006), peak
myocardial systolic velocity (Sm) (11.6 ± 2.3 cm/s vs. 13.9 ± 2.7 cm/s, p = 0.005), isovolumetric contraction velocity
(IVV) (10.3 ± 3 cm/s vs. 14.8 ± 3 cm/s, p < 0.001) and IVA (2.3 ± 0.4 m/s
2 vs. 4.1 ± 0.8 m/s
2, p < 0.001) were
significant lower in the patient group. IVA was the best parameter to predict early systolic dysfunction with an area
under the curve of 0.988.
Conclusion: IVA is a useful tool with high-predictive power to detect early right ventricular systolic impairment in
patients with SSc and without pulmonary hypertension.
Background
Systemic sclerosis is a connective tissue disease charac-
terized by vascular inflammation and fibrosis. Visceral
involvement, e.g. pulmonary fibrosis, pulmonary hyper-
tension, myocardial and renal affliction, is associated
with poor prognosis [1-4]. Cardiac manifestations
include myocardial fibrosis, hypertrophy, coronary and
conduction systems disorders that can lead to severe
clinical complications such as congestive heart failure,
arrhythmias and sudden cardiac death [5].
Primary myocardial involvement and pulmonary
hypertension are common in SSc. According to histolo-
gical and clinical studies, cardiac involvement occurs in
up to 80% of SSc patients [3,6-8]. It often begins in
early stages of the disease and initially remains clinically
asymptomatic. Therefore, early detection of cardiac
involvement in patients with SSc is of clinical impor-
tance to identify patients with higher risk which would
benefit from early medical intervention. Impaired hemo-
dynamic parameters of right ventricular (RV) function
are predictors of poor outcome in patients with SSc. A
good correlation of RV myocardial diastolic dysfunction
and increased pulmonary artery systolic pressure has
been demonstrated [9]. However, pulmonary artery
pressure did not correlate well with impaired RV systolic
function indicating RV systolic dysfunction to be the
result of pulmonary hypertension, disturbance of myo-
cardial microcirculation and myocardial fibrosis [10].
These findings suggest that RV diastolic dysfunction is
the first detectable myocardial manifestation in SSc.
Novel echocardiographic approaches like Tissue Dop-
pler Imaging and Speckle Tracking Strain Imaging
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stolic function in both left and right ventricle and there-
fore led to better detection of subclinical cardiac
involvement in patients with SSc [11,12]. Previous stu-
dies have shown that left ventricular hypertrophy and
diastolic dysfunction often occur in patients with SSc,
while systolic function is frequently only slightly
impaired or normal [13-16].
Isovolumetric acceleration (IVA) is a new tissue Dop-
pler parameter for the assessment of systolic function of
both left and right ventricle. IVA is calculated as the
ratio of Tissue Doppler derived peak myocardial velocity
during isovolumetric contraction (IVV) divided by the
acceleration time (AT). This parameter has been vali-
dated in a variety of experimental and clinical settings.
While IVA remains unaffected by changes in pre- and
afterload within the physiological range, it can detect
small changes in contractile function [17,18]. First clini-
cal studies have demonstrated IVA as a useful sensitive
tool to reveal reduced right ventricular systolic function
[19-22]. It may also be used for early detection of right
ventricular systolic dysfunction [19].
The aim of this study was to assess right ventricular
diastolic and systolic function in patients with SSc with-
out pulmonary hypertension and to evaluate IVA as an
early parameter for the detection of systolic dysfunction
in these patients.
Methods
Study population
Twenty-two patients with SSc (17 women, 5 men,
mean age 57 ± 13.4 years, range 31 to 77 years) were
included into the study. According to serological anti-
body analysis and Rodnan Skin Score, 11 patients had
a limited form and 11 patients suffered from a diffuse
form of SSc. Serological antibody analysis revealed the
presence of anti-centromere pattern in 8 patients, and
anti Scl-70 in 9 patients. All patients presented with
normal pulmonary artery pressure as determined by
transtricuspid conventional Doppler echocardiography.
Three patients with poor RV images were excluded
from the study. For comparison, 22 gender- (17
women, 5 men) and age-matched (mean age 57 ± 13.9
years, range 30 to 78 years) subjects with a clinical
indication for routine echocardiography and normal
findings were used as control group. All participants
provided written consent. The local ethics committee
approved the protocol.
Pulmonary function test
In all patients, a pulmonary function test was performed
(Jaeger MasterScreen, Body/Diff Box; Jaeger; Wuerzburg,
Germany) according to the recommendations of the
American Thoracic Society prior to echocardiography
[23].
Standard echocardiography
Standard echocardiography was performed in the left
decubitus position using an ultrasound system (Vivid 7,
GE Medical Systems, Horton, Norway) with a 3.4-MHz
multifrequency transducer. RV images were obtained
from the parasternal short axis and at the modified api-
cal four-chamber view to optimize RV visualization. The
two RV outflow tract diameters (RVOT1 and RVOT2)
were measured in the two-dimensional parasternal short
axis as recommended by the European Association of
Echocardiography and American Society of Echocardio-
graphy [24]. The RV ejection fraction was estimated by
Simpson’s rule using the apical four-chamber view. The
RV-diameter was also measured in the apical four-
chamber view above the tricuspid annular plane. Tricus-
pid annular plane systolic excursion (TAPSE) as a para-
meter for RV long axis function was assessed with M-
Mode cursor positioned at the free wall angle of the tri-
cuspid valve annulus. From subcostal view the diameter
of the inferior vena cava and the collapsibility index was
measured. Real-time 2D ultrasound data from the RV
free wall with a frame rate greater than 40 frames per
second (fps) were recorded at the apical view for offline
2D strain analysis [Additional file 1 and 2].
Conventional Doppler echocardiography
Tricuspid valve regurgitation was detected at the apical
four-chamber view by colour Doppler echocardiography.
Transtricuspid retrograde velocities were obtained using
continuous-wave Doppler. Systolic pulmonary artery
pressure was estimated from the peak pressure gradient
calculated from three consecutive beats using the modi-
fied Bernoulli formula (ΔP=4 V
2)a n dt h er i g h ta t r i a l
pressure derived by the diameter of the inferior vena
cava and the collapsibility index [24,25].
Tissue Doppler imaging and pulsed-wave TDI
Tissue Doppler Imaging of the RV free wall was per-
formed in the apical four-chamber view at end-expira-
tion. To avoid aliasing, the Nyquist limit was adjusted to
the lowest level. Three consecutive cycles were recorded
with a frame rate greater than 150 fps for offline strain
analysis. Pulsed TDI was performed to measure systolic
and diastolic myocardial velocities at the basal level of
the RV free wall. Peak myocardial isovolumetric con-
traction velocity (IVV), peak myocardial systolic velocity
(Sm), peak early and late diastolic velocities (Em and
Am), isovolumetric contraction time (IVCT), isovolu-
metric relaxation time (IVRT) and ejection time (ET)
were measured [Figures 1 and 2].
Offline analysis
All images were stored digitally for offline analysis
(EchoPac PC Dimension, GE Vingmed). B-Mode images
o ft h eR Vf r e ew a l lw e r eu s e dt om e a s u r e2 Ds t r a i n
using speckle-tracking algorithm. 2D strain in the basal,
mid and apical segment of the RV free wall was
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region of interest (ROI) for TDI strain was placed at
basal, mid and apical segment of the RV free wall. TDI
strain in each segment was averaged over 3 consecutive
cardiac cycles. The myocardial acceleration during iso-
volumetric contraction (IVA), defined as the ratio of
IVV divided by the acceleration time (AT; time to the
peak velocity), and the myocardial performance index or
Tei index, defined as the ratio between total RV isovolu-
metric time (IVCT and IVRT) divided by ejection time
(ET), were also calculated offline [17,26]. The IVA and
AT were measured as follows: The basal and peak
points of the IVV curve were marked. The IVA and AT
were calculated automatically by EchoPac and/or Vivid7
by a previously programmed algorithm.
Inter- and intraobserver variability analysis
Three echocardiographers, blinded to clinical data, inde-
pendently measured IVV and AT and calculated IVA of
10 randomized subjects (five patients and five controls)
for interobserver variability analysis. One observer calcu-
lated IVA twice for the 10 randomized subjects on two
consecutive days for intraobserver variability analysis.
Statistics
Statistics were calculated by software (SPSS, Version
17.0, SPSS Inc, Chicago, Ill). All results are presented as
mean ± standard deviation (SD). The Mann-Whitney
nonparametric test was used to compare echocardio-
graphic data from patients and control subjects. Differ-
ences were considered statistically significant if the P
value was less than 0.05. Receiver-operating characteris-
tic curve analysis was performed to test the diagnostic
accuracy for discrimination of patients from controls
and to determine optimal cut off values. The correlation
was calculated as Pearson’s r coefficient to assess uni-
variate relations. Interclass Correlation Coefficient by
Kolmogorov-Smirnov was used to calculate inter- and
interobserver variability.
Results
Clinical characteristics and pulmonary function test
Age, gender, body mass index, systolic and diastolic
blood pressure as well as the incidence of cardiovascular
risk factors such as hypertension, hypercholesterolemia
and diabetes mellitus did not differ significantly between
patient and control group [Table 1]. The values for dif-
fusion capacity of the lung for carbon monoxide
(DLCO) are presented as a percentage of the predicted
value adjusted for age and hemoglobin. The mean
DLCO value was significantly reduced in the sclero-
derma group (63% of predicted value). In 10 patients
Figure 1 Pulsed wave tissue Doppler imaging of the RV free wall of a control subject. 1: peak myocardial systolic velocity (Sm), 2: peak
early diastolic velocity (Em), 3: peak late diastolic velocity (Am) 4: isovolumetric contraction time (IVCT), 5: ejection time (ET), 6: peak myocardial
isovolumetric contraction velocity (IVV), acceleration time (AT), isovolumetric acceleration (IVA).
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(73%) the DLCO was less than 80% of the predicted
value. The mean systolic pulmonary artery pressure
derived by transtricuspid pressure gradient was 23 ± 4
mmHg in the SSc group.
LV ejection fraction, RV-dimensions and systolic function
at conventional echocardiography
LV ejection fraction was similar in both groups (59.1 ±
4.3% vs. 59.6 ± 1.5%, p = 0.607). There were no signifi-
c a n td i f f e r e n c e si nR V O T 1( 2 9 . 2±4m mv s .2 8 . 7±3 . 4
mm, p = 0.953), RVOT2 (19.7 ± 2.5 mm vs. 20.1 ± 3.3
mm, p = 0.559), RV diameter (31.3 ± 3.5 mm vs. 29.9 ±
2.6 mm, p = 0.184) and RVEF (55.4 ± 12.3% vs. 58.2 ±
8.2%, p = 0.533) between patients and control subjects.
TAPSE as a parameter for RV systolic function mea-
sured in M-mode was significantly smaller in patients
with SSc compared to the control subjects (23.2 ± 4.1
mm vs. 26.5 ± 2.9 mm, p = 0.006).
RV-two-dimensional and tissue Doppler-derived Strain
In speckle tracking strain analysis, peak systolic strain
values were significantly different between both groups
in the basal and medial segments of the RV free lateral
wall with higher values in the control group (-21.6 ±
8.9% vs. -28.2 ± 5.9%, p = 0.024 and -22.4 ± 8% vs.
-29.1 ± 5.8%, p = 0.014 respectively). However, there
was no significant difference in the peak systolic strain
in the apical segment (-23.2 ± 8.5% vs. -27.6 ± 4.6%, p =
0.106). In six controls and three patients, basal and
medial 2D-strain was not measurable due to poor track-
ing. Apical 2D-strain could not be evaluated in five con-
trols and in two patients respectively. DTI-derived peak
systolic strain analysis showed significant differences in
all segments of the RV free lateral wall between the
scleroderma and the control group. Only in one patient,
DTI-derived strain in the medial segment could not be
Figure 2 Pulsed wave tissue Doppler imaging of the RV free wall of an SSc patient. 1: peak myocardial systolic velocity (Sm), 2: peak early
diastolic velocity (Em), 3: peak late diastolic velocity (Am) 4: isovolumetric contraction time (IVCT), 5: ejection time (ET), 6: peak myocardial
isovolumetric contraction velocity (IVV), acceleration time (AT), isovolumetric acceleration (IVA), 7: isovolumetric relaxation time (IVRT-RV).
Table 1 Clinical characteristics, data are expressed as
mean ± SD, except gender, hypertension,
hypercholesterolemia and diabetes mellitus.
Scleroderma
(n = 22)
Control
(n = 22)
p value
Age 57 ± 13.4 57 ± 13.9 0.90
Gender (female) 17 17 1.00
Systolic BP, mmHg 134 ± 21.1 132 ± 16 0.83
Diastolic BP, mmHg 79 ± 8.1 84 ± 9.6 0.17
Body Mass Index, kg/m
2 24.7 ± 5.1 23.3 ± 2.9 0.44
Hypertension 11 13 0.545
Hypercholesterolemia 7 5 0.498
Diabetes mellitus 3 2 0.635
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2].
Pulsed wave TDI
The parameters derived from pulsed wave myocardial
TDI are listed in Table 3. Except early diastolic peak
velocity, all values were statistically significantly lower in
patients with SSc compared to the control group. The
most significant differences were seen for IVRT, IVV,
IVA and MPI with P value < .001 [Table 3].
Comparison between diffuse and limited type of SSc
There are no significant differences among the echo
parameters in patients with diffuse and limited type of
SSc [Table 4].
Receiver operating characteristic analysis
Receiver operating characteristic curve analysis was per-
formed to calculate the best cut-off value to predict
early systolic and diastolic right ventricular dysfunction
in patients with SSc and normal pulmonary arterial
pressure. The best parameter to predict early systolic
d y s f u n c t i o nw a sI V Aw i t ha na r e au n d e rt h ec u r v e
(AUC) of 0.988. An IVA value less than 3.0 m/s
2 had a
sensitivity of 1.0 and a specificity of 0.91 to predict early
systolic right ventricular dysfunction with a positive pre-
dictive value and negative predictive value of 1.0 and
0.92, respectively. The AUC for IVV was 0.861, the peak
systolic myocardial velocity (Sm) had an AUC of 0.747
and TAPSE had an AUC of 0.742 [Figure 3]. For speckle
tracking derived peak systolic strain in the basal, medial
and apical segment the AUC was 0.708, 0.731 and
0.663, respectively. Tissue Doppler derived strain had an
AUC in the basal segment of 0.776, in the medial seg-
ment of 0.74 and in the apical segment of 0.743. IVRT,
a parameter for diastolic dysfunction, had the best AUC
with 0.879. An IVRT of 35 ms in the basal segment of
the free lateral wall had a sensitivity of 0.77 and a speci-
ficity of 0.86 to discriminate patients with SSc and RV
diastolic dysfunction with a positive predictive value of
0.81 and negative predictive value of 0.78. The AUC for
early diastolic velocities (Em) was 0.633 and for late dia-
stolic velocities (Am) 0.771. The myocardial perfor-
mance index (MPI) had an AUC of 0.88.
Correlation of DLCO and RV systolic function
There was no correlation between early-impaired RV
systolic function determined by reduced IVA and the
degree of impaired DLCO in the pulmonary function
test (R
2 Linear = 0.013).
Inter- and intraobserver variability
Inter- and intraobserver variability were found to be
good for IVA with an intraclass correlation coefficient
of 0.97 (CI 0.94-0.99), p < 0.0001 and 0.98 (CI 0.97-
0.99), p < 0.0001.
Discussion
We could demonstrate that in patients with SSc without
pulmonary hypertension systolic and diastolic RV func-
tion was impaired. These findings were independent
from the subtype of disease.
Only three patients could not be included in this
study because of poor RV images. This indicates an
acceptable feasibility of echocardiographic assessment of
RV function in SSc patients.
Tissue Doppler derived peak systolic velocities and
strain as well as two dimensional strain and TAPSE are
useful tools to determine early right ventricular systolic
dysfunction in patients with SSc without Doppler signs
of pulmonary arterial hypertension whereas right ventri-
cular dimension and ejection fraction did not differ sig-
nificantly from the control group. Even though TAPSE
and peak systolic velocity (Sm) were significantly lower
compared to the controls in this study, their respective
values were still within the normal range according to
previously published studies [27-31].
Two-dimensional strain is a new Doppler independent
approach for calculation of strain, strain rate, tissue
velocity, and displacement. It is based on speckle track-
ing analysis in B-Mode and therefore angle independent
[32]. Previous studies used this method to assess the RV
contractility and could show detailed and objective
examination of regional contractile function [33]. We
c o u l dd e m o n s t r a t eag o o dd e t ection of regional systolic
Table 2 Tissue Doppler-derived peak systolic strain, data
are expressed as mean ± SD
Scleroderma
(n = 21)
Control
(n = 22)
P value
DTI-Strain basal, % -24.3 ± 7.2 -28.5 ± 6.4 0.040
DTI-Strain medial, % -26.6 ± 10 -33.4 ± 7.2 0.003
DTI-Strain apical; % -25.2 ± 7.9 -33.1 ± 8 0.004
Table 3 Pulsed- DTI-derived parameters measured at the
free wall angle of the tricuspid valve annulus, data are
expressed as mean ± SD
Scleroderma
(n = 22)
Control
(n = 22)
P value
Sm, cm/s 11.6 ± 2.3 13.9 ± 2.7 0.005
Em, cm/s 11.3 ± 3.4 12.9 ± 3.6 0.128
Am, cm/s 14.1 ± 3.4 19 ± 5.4 0.002
IVV, cm/s 10.3 ± 3 14.8 ± 3 < 0.001
AT, ms 44.6 ± 12.7 37.2 ± 9.8 0.026
IVRT, ms 62.4 ± 34.6 11.7 ± 18.2 < 0.001
IVA, m/s
2 2.3 ± 0.4 4.1 ± 0.8 < 0.001
MPI 0.55 ± 0.22 0.29 ± 0.09 < 0.001
Sm - peak systolic myocardial velocity, Em - early diastolic myocardial velocity,
Am - late diastolic myocardial velocity, IVV - isovolumetric myocardial velocity,
AT - acceleration time, IVRT - isovolumetric relaxation time, IVA - isovolumetric
acceleration, MPI - myocardial performance index
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SSc with acceptable AUC in the ROC analysis. But it
has to be critically considered that not all patients and
controls were fully assessable due to poor tracking of
the right ventricular lateral wall. Therefore, this method
seems to be less reliable in clinical practice for RV
assessment compared to TDI.
IVA is a new sensitive parameter for ventricular con-
tractile function. This parameter has been evaluated in a
variety of experimental and clinical settings
[18,19,34-36]. Several studies have shown that small
changes in contractile function can be detected by mea-
suring IVA while changes in pre- and afterload within
the physiological range did not affect this parameter. In
contrast to tissue Doppler derived peak systolic veloci-
ties, strain and strain rate, IVA is more robust and rela-
tively pre- and afterload-independent [37]. In earlier
clinical studies, it could be shown that IVA measured at
the level of RV tricuspid annulus detects reduced right
ventricular systolic function in relation to the degree of
pulmonary regurgitation in patients after repair of tetral-
ogy of Fallot [21,22]. TDI-derived IVA has been used to
assess a reduction in functional reserve of both ventri-
cles in patients after atrial repair of dextrotransposition
of the great arteries [23]. IVA is also a reliable, noninva-
sive parameter to assess the positive effect of continuous
positive airway pressure (CPAP) therapy in patients with
obstructive sleep apnea syndrome on right ventricular
systolic function [38]. It may be used for early detection
of right ventricular systolic dysfunction in patients with
mitral stenosis without signs of systemic venous conges-
tion [19].
Our findings demonstrate that right ventricular IVA,
derived by pulsed TDI at lateral tricuspid annulus, has
the highest predictive power with the best AUC for
detection of early systolic dysfunction. This parameter
has a low inter- and intraobserver variability and may be
used as an accurate, non-invasive parameter for assess-
ment of RV systolic function in patients with SSc espe-
cially to detect early systolic disturbances. An IVA < 3.0
m/s
2 predicted SSc patients with 100% sensitivity and
91% specificity.
More than 85% of the patients in our study showed a
reduced DLCO. A decreased DLCO is a good predictor
for development of pulmonary hypertension in patients
with SSc and may exist years before pulmonary hyper-
tension is diagnosed [1]. In a correlation analysis, we
could not find a correlation between IVA and the
Table 4 Comparison between scleroderma subtypes, data are expressed as mean ± SD
Diffuse-type SSc Scleroderma
(n = 11)
Limited-type Scleroderma
(n = 11)
P value
Systolic PAP, mmHg 23 ± 6.5 23 ± 2.7 0.562
DLCO, % 56.6 ± 16.5 70.1 ± 13.8 0.065
RVOT 1, mm 29.1 ± 4.3 29.3 ± 3.9 0.847
RVOT 2, mm 20.5 ± 2.5 18.7 ± 2.3 0.114
RV-Diameter, mm 31.2 ± 2.9 31.4 ± 4.2 0.949
RVEF, % 49.9 ± 8.5 52.4 ± 8.8 0.562
TAPSE, mm 22.6 ± 4.6 23.8 ± 3.8 0.591
Sm, cm/s 11.6 ± 2.7 11.5 ± 2.1 1.000
Em, cm/s 10.3 ± 3 12.3 ± 3.7 0.243
Am, cm/s 13.4 ± 3.9 14.7 ± 2.9 0.300
IVV, cm/s 9.7 ± 3.3 10.9 ± 2.7 0.401
AT, ms 44.3 ± 14.3 45 ± 11.5 0.898
IVRT, ms 67 ± 37.8 58 ± 32.3 0.606
IVA, m/s
2 2.2 ± 0.4 2.4 ± 0.4 0.171
MPI 0.61 ± 0.28 0.49 ± 0.12 0.365
2D-Strain basal, % -19.9 ± 7.7 -23.1 ± 10 0.661
2D-Strain medial, % -21.2 ± 6.9 -23.6 ± 9.2 0.604
2D-Strain apical, % -21.8 ± 9.9 -24.4 ± 7.6 0.656
DTI-Strain basal, % -24.5 ± 8.5 -24.1 ± 6.2 0.847
DTI-Strain medial, % -22.7 ± 7.9 -30.8 ± 10.7 0.173
DTI-Strain apical; % -25.2 ± 7.6 -25.1 ± 8.5 0.797
PAP - pulmonary artery pressure, DLCO - diffusing capacity of the lung for carbon monoxide, RVOT - right ventricular outflow tract, RV-diameter - right ventricular
diameter, RVEF - right ventricular ejection fraction, TAPSE - tricuspid annular plane systolic excursion, Sm - peak systolic myocardial velocity, Em - early diastolic
myocardial velocity, Am - late diastolic myocardial velocity, IVV - isovolumetric myocardial velocity, AT - acceleration time, IVRT - isovolumetric relaxation time,
IVA - isovolumetric acceleration, MPI - myocardial performance index
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test. Our findings in principle suggest early RV myocar-
dial affection in these patients independently of pulmon-
ary involvement.
RV function could be affected by an impaired left ven-
tricular function. Hence, left ventricular function was
analyzed in this patient population and control group as
part of routine echocardiography and was found to be
within normal and did not differ between the groups.
Lindqvist et al. could demonstrate an impairment of
RV diastolic function with an increase in RV wall thick-
ness and RA area in patients with SSc and normal pul-
monary artery pressure. Left ventricular function and
right ventricular systolic function were not altered even
though pulmonary artery acceleration time was reduced
in the patient group [39]. As LV function was not
affected, it was difficult for the authors to attribute the
abnormalities of RV diastolic function to myocardial
fibrosis and ischemia due to intermittent coronary
vasospasm alone. They assumed that the most probable
cause is mild or early intermittent pulmonary arterial
hypertension since Doppler echocardiography may
underestimate RV pulmonary pressure calculated from
transtricuspid pressure gradient [40-42]. In agreement
with Lindqvist et al., we obtained pulmonary arterial
pressure from a single measurement at rest. Intermittent
pulmonary hypertension most likely induced by slight
physical exercise cannot be excluded in our patient
population.
Our findings of diastolic RV dysfunction were com-
parable to the results published by Lindqvist et al. In
contrast, we also found significantly reduced systolic
right ventricular function as determined by reduced
IVA. Systolic myocardial velocity (Sm) and TAPSE were
also significantly lower compared to our controls but
still in normal range according to previously published
studies [27-31]. Therefore, Sm and TAPSE alone are not
suitable to predict early systolic dysfunction in patients
with SSc but still useful tools in routine echocardiogra-
phy for RV function assessment to indicate patients
with clinical relevant RV systolic dysfunction. IVA is
calculated as the ratio of IVV divided by AT. We found
higher values for IVV in our control group compared to
the results of Linqvist et al. [39]. However, our IVV
values in the control group conform to normal values
for IVV published by the same author earlier [30].
Study Limitations
The duration of IVA lies in the range of 20-40 msec.
Therefore, even with high frame rate approaches like
Tissue Doppler Imaging (130-250 fps), were data are
acquired every 4-6 msec., low temporal resolution due
to technical limitations might represent a relevant
source of error. Like all Doppler measurements, IVA is
angle dependent. In malpositioned hearts or transducers
when the angle of Doppler signal cannot be aligned
optimally significant differences may occur. Further-
more, IVA is age-dependent. The highest IVA will be
found in the 2
nd decade of life, with a progressive
Figure 3 Receiver operating characteristic curve analysis for IVV - isovolumetric myocardial velocity, IVA - isovolumetric acceleration,
S - peak systolic myocardial velocity and TAPSE - tricuspid annular plane systolic excursion. IVA shows the best area under the curve
(0.988) to predict early systolic dysfunction.
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range in our study population was wide from 31 to 77
years with a mean age of 57.5 ± 12.9 years. To avoid
age-dependent bias, our control group was age-matched
with a similar range (mean age 57.4 ± 13.4 years, range
30 to 78 years). It was not part of the study protocol to
perform right-heart-catheterization to verify our echo-
cardiographic results with invasively measured pulmon-
ary artery pressure.
Conclusions
This study demonstrated an early RV systolic and dia-
stolic dysfunction in patients with SSc without Doppler
indices for pulmonary hypertension. IVA is a new TDI
derived index of contractile function with high sensitiv-
ity and specificity. IVA is a useful tool with high-predic-
tive power to detect early right ventricular systolic
impairment in these patients. With a low intra- and
interobserver variability this parameter is easy to mea-
sure and not influenced by loading conditions in the
physiological range. In order to detect RV- systolic dys-
function as well as diastolic dysfunction in early stages
of SSc, further multicenter studies with larger patient
numbers are needed to evaluate this parameter for clini-
cal practice.
Additional file 1: Control subject: 2D longitudinal strain of the right
ventricle. Control subject: 2D longitudinal strain of the right ventricle.
The values of the basal, mid and apical segment of the free lateral wall
were taken for further analysis.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-7120-8-3-
S1.AVI]
Additional file 2: SSc patient: 2D longitudinal strain of the right
ventricle. SSc patient: 2D longitudinal strain of the right ventricle. The
values of the basal, mid and apical segment of the free lateral wall were
taken for further analysis.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-7120-8-3-
S2.AVI]
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